Retour
Fourchette du Jour
28,65 €
29,39 €
Fourchette 52 Semaines
12,47 €
37,35 €
Volume
4 106 809
Moyenne 50J / 200J
32,63 €
/
23,84 €
Clôture Précédente
28,73 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 23,8 | 0,4 |
| P/B | 4,2 | 2,9 |
| ROE % | 21,2 | 3,7 |
| Net Margin % | 8,2 | 3,9 |
| Rev Growth 5Y % | 2,1 | 10,0 |
| D/E | 2,2 | 0,2 |
Objectif de Cours des Analystes
Hold
38,33 €
+33.2%
Low: 35,00 €
High: 41,00 €
P/E Prévisionnel
10,6
BPA Prévisionnel
2,70 €
Croissance BPA (est.)
+0,0%
CA Est.
17 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,06 €
4,01 € – 4,12 €
|
19 B | 1 |
| FY2029 |
3,58 €
3,54 € – 3,64 €
|
18 B | 1 |
| FY2028 |
3,44 €
2,25 € – 4,45 €
|
18 B | 3 |
Points Clés
Revenue grew 2,10% annually over 5 years — modest growth
ROE of 21,23% indicates high profitability
Debt/Equity of 2,20 — high leverage
Generating 1,15B in free cash flow
Cash machine — converts 81,42% of earnings into free cash flow
Capital efficient — spends only 2,90% of revenue on capex
Croissance
Revenue Growth (5Y)
2,10%
Revenue (1Y)4,31%
Earnings (1Y)N/A
FCF Growth (3Y)16,77%
Qualité
Return on Equity
21,23%
ROIC6,40%
Net Margin8,17%
Op. Margin12,50%
Sécurité
Debt / Equity
2,20
Current Ratio1,04
Interest Coverage2,35
Valorisation
P/E Ratio
23,76
P/B Ratio4,24
EV/EBITDA21,94
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,31% | Revenue Growth (3Y) | 4,36% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2,10% | Earnings Growth (5Y) | 35,60% |
| Profitability | |||
| Revenue (TTM) | 17,26B | Net Income (TTM) | 1,41B |
| ROE | 21,23% | ROA | 3,46% |
| Gross Margin | 51,79% | Operating Margin | 12,50% |
| Net Margin | 8,17% | Free Cash Flow (TTM) | 1,15B |
| ROIC | 6,40% | FCF Growth (3Y) | 16,77% |
| Safety | |||
| Debt / Equity | 2,20 | Current Ratio | 1,04 |
| Interest Coverage | 2,35 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 23,76 | P/B Ratio | 4,24 |
| P/S Ratio | 1,94 | PEG Ratio | -0,14 |
| EV/EBITDA | 21,94 | Dividend Yield | 0,00% |
| Market Cap | 33,51B | Enterprise Value | 47,33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17,26B | 16,54B | 15,85B | 14,93B | 15,88B |
| Net Income | 1,41B | -1,64B | -559,00M | -2,45B | 417,00M |
| EPS (Diluted) | 1,20 | -1,45 | -0,50 | -2,20 | 0,38 |
| Gross Profit | 8,94B | 8,06B | 7,65B | 6,97B | 7,59B |
| Operating Income | 2,16B | -303,00M | 433,00M | -2,20B | 1,72B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40,75B | 39,33B | 43,48B | 44,01B | 47,67B |
| Total Liabilities | 32,83B | 33,61B | 35,35B | 35,41B | 36,42B |
| Shareholders' Equity | 7,91B | 5,37B | 7,51B | 7,80B | 10,28B |
| Total Debt | 17,38B | 18,08B | 20,15B | 21,56B | 23,46B |
| Cash & Equivalents | 3,56B | 3,30B | 3,23B | 2,80B | 2,17B |
| Current Assets | 13,95B | 12,55B | 12,49B | 12,05B | 12,57B |
| Current Liabilities | 13,46B | 12,80B | 12,25B | 11,47B | 11,03B |